| CSL Behring AG - Hepatitis-B-Immunglobulin Behring, Injektionslösung |
| 00674 | | 01 | | Hepatitis-B-Immunglobulin Behring | | Injektionslösung | | J06BB04 | | Hepatitis-B-Immunglobulin | | 01.03.2004 | | |
|
| Composition |
| immunoglobulinum humanum hepatitidis B min. 200 U.I. corresp. immunoglobulinum humanum normale min. 95 % corresp. proteina 100-170 mg, immunoglobulinum humanum A max. 3.0 mg, glycinum, natrii chloridum corresp. natrium max. 1.18 mg, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | Principe actif | Concentr. |
|---|
| Immunoglobulinum Humanum Hepatitidis B | 200 UI/ml correspond Immunoglobulinum Humanum Normale 95 %/ml |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acidum Hydrochloridum | | | Glycine | | | Immunoglobulinum Humanum A | 3 mg/ml | | Sodium Chlorure | | | Sodium Hydroxide | |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | 1 ml | | | B | | Non | | 004 | 5 ml | | | B | | Non |
|
